Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Extension of Study ZPV-200

This study has been completed.
Information provided by (Responsible Party):
Repros Therapeutics Inc. Identifier:
First received: June 27, 2012
Last updated: April 15, 2014
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)